Intelligent Bio Solutions Inc. (NASDAQ:INBS) on Wednesday announced that Managed Waste Service plans to implement INBS' Intelligent Fingerprinting Drug Screening System across its New South Wales ...

Customers identify in-house control, project flexibility, productivity, and cost reductions as key business benefits of fingerprint sweat-based drug testing Construction and manufacturing firms ...

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing ...

Intelligent Bio Solutions partners with Spjotgard to enhance fingerprint drug testing adoption in Scandinavia, addressing rising demand for non-invasive solutions. Intelligent Bio Solutions Inc.

NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing ...

NEW YORK, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing ...

NEW YORK, July 06, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company developing and delivering intelligent, rapid, ...

Detailed price information for Intelligent Bio Solutions Inc (INBS-Q) from The Globe and Mail including charting and trades.

As the Company pursues FDA approval of its Intelligent Fingerprinting Drug Screening System and advances plans to enter the U.S. market this year, the event provides a unique platform for INBS to ...

NEW YORK, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), today announced that global garden equipment manufacturer Hozelock will implement drug tests ...

Quantum TM adopts INBS’ fingerprint drug testing for faster, more efficient workplace screening across 10 UK sites. INBS plans US expansion in 2025 after FDA submission, aiming to tap into the growing ...